Sign in
TerminatedNo phase

Violet Light for the Suppression of Myopia

Key facts

Who runs it
Children's Hospital Medical Center, Cincinnati
Where
Cincinnati, United StatesSee the site
Trial code
Status
Terminated
People taking part
65 people enrolled
Started
7 Jun 2023
Ended
6 Jul 2026
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Violet Light Lamp
  • White Light Lamp
Record updated
10 July 2026
Why it stopped
Recruitment issues.

Who can take part

Age
5 years to 12 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Children must be between 5 to <13 years old
  • Diagnosis of Myopia (ICD-10-CM Diagnosis; Code H52.13) with refractive error:
  • Myopia -1.00D to -6.00D spherical equivalent (SE) in both eyes
  • Astigmatism <=1.50D in both eyes
  • Anisometropia <=1.00D SE • Relocation outside of the CCHMC area within the next 12 months is not anticipated

Who cannot take part

  • Current or previous myopia treatment with atropine, pirenzepine, or other antimuscarinic agents
  • Current or previous use of bifocals, progressive addition lenses, or multi-focal contact lenses
  • Current or previous use of orthoK, rigid gas permeable, or other contact lenses being used to reduce myopia progression
  • Current or prior history of manifest strabismus, amblyopia, or nystagmus
  • Prior eyelid, strabismus, intraocular, or refractive surgery
  • Down syndrome or cerebral palsy
  • Abnormality of cornea, lens, central retina, iris, or ciliary body

Where in United States

  • Cincinnati Children's Hospital Medical CenterCincinnati, United States

About the trial

What the trial wants to find out

The study explores the suppression of myopia via violet light.

The 3 groups in the trial

  • Violet + / Lens +Treatment being tested

    Subjects use a violet light emitting lamp (device intervention - minimally invasive as it's simply a source of light) with CR-39 lenses for their refractive correction. The lamp introduces violet light (Violet +) and the CR-39 lenses allow for the transmission of violet light through the lenses (Lens +).

    Treatment: Violet Light Lamp

  • Violet + / Lens -Treatment being tested

    Subjects use a violet light emitting lamp (device intervention - minimally invasive as it's simply a source of light) with polycarbonate lenses for their refractive correction. The lamp introduces violet light (Violet +) while the polycarbonate lenses block the transmission of violet light through the lenses (Lens -).

    Treatment: Violet Light Lamp

  • Violet - / Lens +Placebo, for comparison

    Subjects use a lamp with NO violet light (Violet -) with CR-39 lenses for their refractive correction. CR-39 lenses allow for the transmission of violet light through the lenses (Lens +).

    Treatment: White Light Lamp

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Violet Light for Treatment of Myopia
Record updated
10 July 2026